Pharmacy World and Science

, Volume 17, Issue 6, pp 177–177 | Cite as

Adverse drug reactions: more than a warning!

  • Lolkje de Jong-van den Berg


Adverse effects Angiotensin-converting enzyme inhibitors Drug design 


  1. 1.
    Rikken F, Vos R. How adverse drug reactions can play a role in innovative drug research. Similarities in adverse drug reaction profiles of captopril and penicillamine. Pharm World Sci 1995;17(6):195–200.PubMedGoogle Scholar
  2. 2.
    Kurt U, Ozkardes H, Altug U, Germiyanoglu C, Gurdal M, Erol D. The efficacy of anti-serotoninergic agents in the treatment of erectile dysfunction. J Urol 1994;152:407–9.PubMedGoogle Scholar
  3. 3.
    Gansevoort RT, de Zeeuw R, de Jong PE. Effects of ACE inhibitors and Ang II antagonism. Is the antiproteinuric effect of ACE inhibition mediated by interference in the reninangiotensin system? Kidney Int 1994;45:861–7.PubMedGoogle Scholar
  4. 4.
    Herings RMC, Stricker BHC, Leufkens HGM, Bakker A, Sturmans F, Urquhart J. Public health and the rapid estimation of the size of the population at risk. Torsades de pointes and the use of terfenadine and astemizole in the Netherlands. Pharm World Sci 1993;15(5):212–8.PubMedGoogle Scholar

Copyright information

© Royal Dutch Association for the Advancement of Pharmacy 1995

Authors and Affiliations

  • Lolkje de Jong-van den Berg
    • 1
  1. 1.Department of Social Pharmacy and Pharmacoepidemiology, Groningen Institute of Drug StudiesUniversity of GroningenAW GroningenThe Netherlands

Personalised recommendations